Affiliations: Hematology
Center of the MGH Cancer Center
Research Interests:
In collaboration with MGH Hematology and with other clinical divisions at MGH, the Blood Transfusion Service conducts clinical research in the disciplines of transfusion medicine, hemostasis and thrombophilia. The Blood Transfusion Service is a member of the NHLBI Clinical Trials Network in Transfusion Medicine and Hemostasis.
In 2000-2001, we were principal investigators of a large randomized clinical trial of leukoreduction technology. This study highlighted the opportunity at MGH to conduct clinical research that crosses a broad variety of medical disciplines.
Dr Dzik is a founding member of the Biomedical Excellence for Safer Transfusion (BEST) Research Collaborative. In 2002, Dr Dzik led a large, international, multicenter BEST Study focused on blood grouping errors due to miscollected samples. A previous international study with this group focused on standardization of CD34+ cell counting during progenitor cell collections.
In addition to these large clinical trials, Sunny Dzik's research interests include management of the coagulopathy of liver disease, clinical use of blood components, biologic consequences of recipient exposure to allogeneic donor leukocytes, and patient safety in transfusion. Studies are underway on the application of Radiofrequency Identification for improved patient safety at the time of transfusion.
Dr Dzik is an Associate Editor of Transfusion and Transfusion Medicine Reviews. In addition, he is devoted to mentoring the next generation of leaders in academic Transfusion Medicine. He is currently assisting a former MGH trainee on a research project underway in Uganda which is studying the role of blood groups in P falciparum malaria. Dr Dzik is a member of the MGH Program in Global Health with a special interest in laboratory and intensive care resources at Mulago Hospital in Uganda.
|
